Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
glycopyrronium bromide 1mg tablets
special order - glycopyrronium bromide - oral tablet - 1mg
Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
glycopyrronium bromide 1mg tablets
alliance healthcare (distribution) ltd - glycopyrronium bromide - oral tablet - 1mg
Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
glycopyrronium bromide 1mg tablets
a a h pharmaceuticals ltd - glycopyrronium bromide - oral tablet - 1mg
Irland -
Englisch -
HPRA (Health Products Regulatory Authority)
glycopyrronium bromide 200 micrograms/ml solution for injection
martindale pharmaceuticals ltd - glycopyrronium bromide - solution for injection - 200 microgram(s)/millilitre - synthetic anticholinergics, quaternary ammonium compounds; glycopyrronium bromide
Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
glycopyrronium bromide 1mg tablets
accord-uk ltd - glycopyrronium bromide - oral tablet - 1mg
Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
glycopyrronium bromide 1mg tablets
p.i.e. pharma ltd - glycopyrronium bromide - oral tablet - 1mg
Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
glycopyrronium bromide 1mg tablets
de pharmaceuticals - glycopyrronium bromide - oral tablet - 1mg
Vereinigtes Königreich -
Englisch -
MHRA (Medicines & Healthcare Products Regulatory Agency)
glycopyrronium bromide 1mg tablets
teva uk ltd - glycopyrronium bromide - oral tablet - 1mg
Irland -
Englisch -
HPRA (Health Products Regulatory Authority)
glycopyrronium bromide 200 micrograms/ml solution for injection
mercurypharm ltd - glycopyrronium bromide - solution for injection - 200 microgram(s)/millilitre - synthetic anticholinergics, quaternary ammonium compounds; glycopyrronium bromide
Australien -
Englisch -
Department of Health (Therapeutic Goods Administration)
enerzair breezhaler 114/46/68 indacaterol/glycopyrronium/mometasone furoate 114/46/68 microgram powder for inhalation in capsule with inhaler
novartis pharmaceuticals australia pty ltd - glycopyrronium bromide, quantity: 63 microgram (equivalent: glycopyrronium, qty 50 microgram); mometasone furoate, quantity: 80 microgram; indacaterol acetate, quantity: 173 microgram (equivalent: indacaterol, qty 150 microgram) - capsule, hard - excipient ingredients: lactose monohydrate; magnesium stearate - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.